Biomarin Pharmaceutical shares owned by Wellesley Investment Advisors
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Wellesley Investment Advisors
from 13F filings
Historical chart of Wellesley Investment Advisors investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Wellesley Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $42B | 41M | 1033.35 |
| 2023-09-30 | $47B | 47M | 994.37 |
| 2023-06-30 | $43B | 43M | 1010.76 |
| 2023-03-31 | $34B | 32M | 1039.35 |
| 2022-12-31 | $56M | 52k | 1068.64 |
| 2022-09-30 | $52M | 52k | 1002.29 |
| 2022-06-30 | $51M | 51k | 1003.78 |
| 2022-03-31 | $30M | 30k | 1007.12 |
| 2021-12-31 | $48M | 46k | 1041.88 |
| 2021-09-30 | $33M | 33k | 1005.82 |
More positions owned by Wellesley Investment Advisors
View all positions for Wellesley Investment Advisors